SIGA — SIGA Technologies Share News
0.000.00%
Last trade - 00:00- $228.48m
- $110.90m
- $94.57m
SIGA Technologies Q2 revenue, profit drop as contract ends
SIGA Technologies Q1 revenue falls, net loss widens
Brief: SIGA Technologies Q1 EPS USD -0.05
Brief: EMA Recommends Restricting Use Of Tecovirimat SIGA
SIGA Technologies 2025 revenue falls
Brief: SIGA Technologies FY EPS USD 0.32
Antiviral therapeutics developer SIGA Q3 revenue plummets on lower TPOXX deliveries
Pharma firm SIGA Q2 product revenues rise
Brief: EMA's CHMP Starts Review Of Tecovirimat SIGA
Brief: NIH Says Tecovirimat Is Safe But Ineffective As Treatment For Clade II Mpox
Brief: Tepoxx Approved In Japan For The Treatment Of Orthopoxviruses
Brief: Interim Results From Stomp Study Of Siga’S Tecovirimat In Treatment Of Mpox Announced
Siga's mpox drug did not improve lesion resolution or pain, NIH study finds (updated)
Refile: Siga's mpox drug did not improve lesion resolution or pain, NIH study finds
Newscasts - US indictments send India's Adani Group firms into $27 bln tumble
Newscasts - US indictments send India's Adani Group firms into $27 bln tumble
Cluster of drug-resistant mpox identified in five states, US officials report
Siga Technologies to supply mpox therapy in Morocco (updated)
Brief: Siga Announces Agreement To Supply Tpoxx In Morocco